EZR and soft tissue sarcoma: Previously, a meta‐analysis was conducted to evaluate the prognostic value of high ezrin expression in patients with solid tumors, including bone and soft tissue sarcomas 20; however, the number of included studies was limited (n = 9), and therefore, the results were inconclusive.